Succinylacetone as primary marker to detect tyrosinemia type I in newborns and its measurement by newborn screening programs

Medicine & Life Sciences

• succinylacetone 100%
• Tyrosinemias 87%
• Neonatal Screening 67%
• Newborn Infant 44%
• Tyrosine 9%
• fumarylacetoacetase 9%
• United States Dept. of Health and Human Services 7%
• Tandem Mass Spectrometry 5%
• Liver Failure 5%
• Advisory Committees 5%
• Centers for Disease Control and Prevention (U.S.) 5%
• Health Services 4%
• Liver Diseases 4%
• Nervous System 4%
• Child 2%
• Population 2%
• Therapeutics 0%

Chemical Compounds

• Marker 50%
• Tandem Mass Spectrometry 47%
• Tyrosine 34%
• Disorder 16%